Related references
Note: Only part of the references are listed.A novel linker methodology for the synthesis of tailored conjugate vaccines composed of complex carbohydrate antigens and specific T-H-cell peptide epitopes
Sebastian Dziadek et al.
CHEMISTRY-A EUROPEAN JOURNAL (2008)
Robust immune responses elicited by a fully synthetic three-component vaccine
Sampat Ingale et al.
NATURE CHEMICAL BIOLOGY (2007)
Synthetic vaccines of tumor-associated glycopeptide antigens by immune-compatible thioether linkage to bovine serum albumin
Sven Wittrock et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2007)
Advances in combating fungal diseases: vaccines on the threshold
Jim E. Cutler et al.
NATURE REVIEWS MICROBIOLOGY (2007)
Hybridoma passage in vitro may result in reduced ability of antimannan antibody to protect against disseminated candidiasis
Hong Xin et al.
INFECTION AND IMMUNITY (2006)
Immune sensing of Candida albicans requires cooperative recognition of mannans and glucans by lectin and Toll-like receptors
Mihai G. Netea et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
A fungicidal monoclonal antibody protects against murine invasive candidiasis
MJ Sevilla et al.
INFECTION AND IMMUNITY (2006)
Polysaccharide-containing conjugate vaccines for fungal diseases
A Casadevall et al.
TRENDS IN MOLECULAR MEDICINE (2006)
Association between atopy and recurrent vaginal candidiasis
NA Neves et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2005)
A novel glyco-conjugate vaccine against fungal pathogens
A Torosantucci et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Synthesis of glycoconjugate vaccines for Candida albicans using novel linker methodology
XY Wu et al.
JOURNAL OF ORGANIC CHEMISTRY (2005)
History and new insights into host defense against vaginal candidiasis
PL Fidel
TRENDS IN MICROBIOLOGY (2004)
DCs as targets for vaccine design
GT Belz et al.
CYTOTHERAPY (2004)
A synthetic conjugate polysaccharide vaccine against Haemophilus influenzae type b
V Verez-Bencomo et al.
SCIENCE (2004)
The immunogenicity of the tumor-associated antigen Lewisy may be suppressed by a bifunctional cross-linker required for coupling to a carrier protein
T Buskas et al.
CHEMISTRY-A EUROPEAN JOURNAL (2004)
Proteomics-based identification of novel Candida albicans antigens for diagnosis of systemic candidiasis in patients with underlying hematological malignancies
A Pitarch et al.
PROTEOMICS (2004)
Antibody-mediated regulation of cellular immunity and the inflammatory response
A Casadevall et al.
TRENDS IN IMMUNOLOGY (2003)
Preclinical assessment of the efficacy of mycograb, a human recombinant antibody against fungal HSP90
RC Matthews et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
ProPred1: prediction of promiscuous MHC Class-I binding sites
H Singh et al.
BIOINFORMATICS (2003)
Immunogenicity in a mouse model of a conjugate vaccine made with a synthetic single repeating unit of type 14 pneumococcal polysaccharide coupled to CRM197
F Mawas et al.
INFECTION AND IMMUNITY (2002)
A novel bulk-culture method for generating mature dendritic cells from mouse bone marrow cells
YI Son et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2002)
The unique solution structure and immunochemistry of the Candida albicans β-1,2-mannopyranan cell wall antigens
M Nitz et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
ProPred: prediction of HLA-DR binding sites
H Singh et al.
BIOINFORMATICS (2001)
Complement is essential for protection by an IgM and an IgG3 monoclonal antibody against experimental, hematogenously disseminated candidiasis
YM Han et al.
JOURNAL OF IMMUNOLOGY (2001)
Whole recombinant yeast vaccine activates dendritic cells and elicits protective cell-mediated immunity
AC Stubbs et al.
NATURE MEDICINE (2001)
Prostaglandin E2 up-regulates macrophage-derived chemokine production but suppresses IFN-Inducible protein-10 production by APC
E Kuroda et al.
JOURNAL OF IMMUNOLOGY (2001)